風邪およびインフルエンザサプリメントの世界市場レポート 2025年

風邪およびインフルエンザサプリメントの市場規模は、今後数年で急成長が見込まれます。2029年には複合年間成長率（CAGR）12.9%で368億2,000万米ドルに成長します。予測期間中に予想される成長は、呼吸器感染症の罹患率の上昇、季節性インフルエンザの負担増、免疫補助食品に対する需要の高まり、栄養補助食品の利点に対する意識の高まり、天然および植物ベースのハーブエキスに対する嗜好の高まりに起因しています。この期間に予想される主な動向には、革新的な製品処方、個別化医療の台頭、的を絞ったソリューションの開発、栄養科学の進歩などがあります。

季節性疾患の罹患率の増加が、今後数年間の風邪およびインフルエンザサプリメント市場の成長を後押しすると予想されます。季節性疾患とは、1年のうち特定の時期に頻発する疾患で、天候や気候、環境条件の変化に影響されることが多いです。これらの疾病の発生が増加しているのは、気温や湿度のパターンを乱し、それによって感染シーズンを延長し、インフルエンザなどのウイルスの蔓延を促進する気候変動が主な原因です。風邪およびインフルエンザサプリメントは、免疫力を高め、症状の重症度を最小限に抑え、早期回復を促すことで、季節性疾患の管理に貢献します。例えば、2025年1月、日本の非営利団体である日本コミュニケーション財団は、2024年12月に日本におけるインフルエンザの患者数が過去最高の31万7,812人に急増したと報告しました。さらに2023年11月、米国の政府機関である労働統計局は、民間企業の従業員1万人当たりの罹患率が、2021年の37.7人から2022年には45.2人に上昇したと発表しました。その結果、季節性疾患の頻度の増加が風邪およびインフルエンザサプリメントの需要を促進しています。

風邪およびインフルエンザサプリメント市場の大手企業は、1回の服用で総合的な症状緩和を提供し、消費者の利便性と効能の両方を向上させるオールインワン型多症候性治療薬などの製品で革新を図っています。これらのオールインワン製剤は、鼻づまり、咳、発熱、体の痛みなど、様々な風邪やインフルエンザの症状を同時に緩和するように設計されており、総合的な解決策を提供します。例えば、2024年1月、英国の健康・衛生・栄養関連企業であるReckitt Benckiser Group plcは、朝の風邪やインフルエンザの症状を素早く緩和することを目的とした新製品、Fast-Max Kickstartを発売しました。この製品は、鼻づまり、のどの痛み、体の痛みを効果的に和らげる速効性のある成分を配合しており、消費者が一日を快適にスタートできるようサポートします。また、独特の清涼感で、イライラを和らげながらリフレッシュできます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の風邪およびインフルエンザサプリメント PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の風邪およびインフルエンザサプリメント市場：成長率分析
• 世界の風邪およびインフルエンザサプリメント市場の実績：規模と成長, 2019-2024
• 世界の風邪およびインフルエンザサプリメント市場の予測：規模と成長, 2024-2029, 2034F
• 世界の風邪およびインフルエンザサプリメント総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の風邪およびインフルエンザサプリメント市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンとミネラル
• ハーブエキス
• 天然分子
• 世界の風邪およびインフルエンザサプリメント市場：剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤とカプセル
• 粉
• シロップ
• その他の剤形
• 世界の風邪およびインフルエンザサプリメント市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬局とドラッグストア
• ハイパーマーケットとスーパーマーケット
• オンライン
• その他の流通チャネル
• 世界の風邪およびインフルエンザサプリメント市場、ビタミンとミネラル、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンC
• ビタミンD
• 亜鉛
• セレン
• マグネシウム
• 世界の風邪およびインフルエンザサプリメント市場、ハーブエキス、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• エキナセアエキス
• エルダーベリーエキス
• ショウガエキス
• ウコンエキス
• 高麗人参エキス
• 世界の風邪およびインフルエンザサプリメント市場、天然分子、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• フラボノイド
• ポリフェノール
• エッセンシャルオイル
• プロバイオティクス
• アミノ酸

第7章 地域別・国別分析

• 世界の風邪およびインフルエンザサプリメント市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の風邪およびインフルエンザサプリメント市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 風邪およびインフルエンザサプリメント市場：競合情勢
• 風邪およびインフルエンザサプリメント市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Reckitt Benckiser Group plc
• Haleon plc
• Perrigo Company plc
• Amway Corporation
• Nu Skin Enterprises Inc.
• The Vitamin Shoppe Inc.
• NOW Health Group Inc.
• Nature's Sunshine Products Inc.
• Nature's Way Products LLC
• Nordic Naturals Inc.
• Orthomol GmbH
• Weefsel Pharma Pvt. Ltd.
• AdvaCare Pharma USA
• Zarbee's Naturals LLC
• Neurobiologix Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 風邪およびインフルエンザサプリメント市場2029：新たな機会を提供する国
• 風邪およびインフルエンザサプリメント市場2029：新たな機会を提供するセグメント
• 風邪およびインフルエンザサプリメント市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cold and flu supplements are dietary products designed to support the immune system and help relieve symptoms associated with colds and the flu. They are commonly used to boost immunity, reduce congestion, soothe sore throats, and aid in overall recovery.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

These supplements primarily include vitamins and minerals, herbal extracts, and natural molecules. Vitamins and minerals are vital nutrients that contribute to key bodily functions such as immune support, energy production, and cell repair. They are available in various forms, including tablets and capsules, powders, syrups, and others, and are distributed through multiple channels such as pharmacies and drug stores, hypermarkets and supermarkets, online platforms, and other outlets.

The cold and flu supplements market research report is one of a series of new reports from The Business Research Company that provides cold and flu supplements market statistics, including the cold and flu supplements industry global market size, regional shares, competitors with the cold and flu supplements market share, detailed cold and flu supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the cold and flu supplements industry. These cold and flu supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold and flu supplements market size has grown rapidly in recent years. It will grow from$19.98 billion in 2024 to $22.63 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth during the historic period can be attributed to an increasing aging population, a rise in flu cases, enhanced government support, growing consumer purchasing power, and increased spending on products that boost immune health.

The cold and flu supplements market size is expected to see rapid growth in the next few years. It will grow to$36.82 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth anticipated in the forecast period can be attributed to the rising incidence of respiratory infections, an increasing burden of seasonal influenza, growing demand for immune support supplements, heightened awareness of the benefits of dietary supplements, and a rising preference for natural and plant-based herbal extracts. Key trends expected during this period include innovative product formulations, the emergence of personalized medicine, development of targeted solutions, and advances in nutritional sciences.

The increasing incidence of seasonal diseases is expected to boost the growth of the cold and flu supplements market in the coming years. Seasonal diseases are ailments that occur more frequently during specific times of the year, often influenced by changes in weather, climate, or environmental conditions. The rising occurrence of these illnesses is largely attributed to climate change, which disrupts temperature and humidity patterns, thereby extending transmission seasons and facilitating the spread of viruses such as influenza. Cold and flu supplements contribute to managing seasonal illnesses by boosting immunity, minimizing symptom severity, and promoting quicker recovery. For example, in January 2025, the Nippon Communications Foundation, a Japan-based non-profit organization, reported that influenza cases in Japan surged to a record 317,812 in December 2024. Additionally, in November 2023, the Bureau of Labor Statistics, a US-based government agency, noted that the illness rate among private industry employees rose to 45.2 cases per 10,000 full-time equivalent workers in 2022, up from 37.7 cases in 2021. As a result, the growing frequency of seasonal diseases is fueling demand for cold and flu supplements.

Leading players in the cold and flu supplements market are innovating with products such as all-in-one multi-symptom remedies to provide comprehensive symptom relief in a single dose, improving both convenience and efficacy for consumers. These all-in-one formulations are designed to simultaneously alleviate various cold and flu symptoms-including congestion, cough, fever, and body aches-offering a holistic solution. For instance, in January 2024, Reckitt Benckiser Group plc, a UK-based health, hygiene, and nutrition company, launched Fast-Max Kickstart, a new product aimed at delivering fast relief for morning cold and flu symptoms. The formulation features rapid-acting ingredients that effectively ease congestion, sore throat, and body aches, helping consumers start their day more comfortably. Its distinct cooling sensation also offers a refreshing effect while soothing irritation.

In September 2023, Sanofi S.A., a France-based pharmaceutical firm, acquired Qunol LLC for $1.4 billion. This acquisition is part of Sanofi's strategy to enhance its consumer healthcare portfolio by increasing its footprint in the wellness and dietary supplements sector. By integrating Qunol's widely recognized brand-particularly known for products supporting heart health and immune function-Sanofi aims to capitalize on growing demand for preventive health solutions, including those that assist in managing cold and flu symptoms. Qunol LLC is a US-based producer of immune support supplements geared toward reducing the impact of cold and flu ailments.

Major players in the cold and flu supplements market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi SA, Reckitt Benckiser Group plc, Haleon plc, Perrigo Company plc, Amway Corporation, Nu Skin Enterprises Inc., The Vitamin Shoppe Inc., NOW Health Group Inc., Nature's Sunshine Products Inc., Nature's Way Products LLC, Nordic Naturals Inc., Orthomol GmbH, Weefsel Pharma Pvt. Ltd., AdvaCare Pharma USA, Zarbee's Naturals LLC, and Neurobiologix Inc.

North America was the largest region in the cold and flu supplements market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold and flu supplements report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold and flu supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and flu supplements market consists of sales of effervescent tablets, lozenges, herbal teas, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold And Flu Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold and flu supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cold and flu supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold and flu supplements market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Vitamins And Minerals; Herbal Extracts; Natural Molecules
• 2) By Form: Tablets And Capsules; Powder; Syrup; Other Forms
• 3) By Distribution Channel: Pharmacies And Drug Stores; Hypermarkets And Supermarkets; Online; Other Distribution Channels
• Subsegments:
• 1) By Vitamins and Minerals: Vitamin C; Vitamin D; Zinc; Selenium; Magnesium
• 2) By Herbal Extracts: Echinacea Extract; Elderberry Extract; Ginger Extract; Turmeric Extract; Ginseng Extract
• 3) By Natural Molecules: Flavonoids; Polyphenols; Essential Oils; Probiotics; Amino Acids
• Companies Mentioned: Pfizer Inc.; The Procter & Gamble Company; Johnson & Johnson; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cold And Flu Supplements Market Characteristics

3. Cold And Flu Supplements Market Trends And Strategies

4. Cold And Flu Supplements Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold And Flu Supplements Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cold And Flu Supplements PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cold And Flu Supplements Market Growth Rate Analysis
• 5.4. Global Cold And Flu Supplements Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cold And Flu Supplements Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cold And Flu Supplements Total Addressable Market (TAM)

6. Cold And Flu Supplements Market Segmentation

• 6.1. Global Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamins And Minerals
• Herbal Extracts
• Natural Molecules
• 6.2. Global Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets And Capsules
• Powder
• Syrup
• Other Forms
• 6.3. Global Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacies And Drug Stores
• Hypermarkets And Supermarkets
• Online
• Other Distribution Channels
• 6.4. Global Cold And Flu Supplements Market, Sub-Segmentation Of Vitamins And Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin C
• Vitamin D
• Zinc
• Selenium
• Magnesium
• 6.5. Global Cold And Flu Supplements Market, Sub-Segmentation Of Herbal Extracts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Echinacea Extract
• Elderberry Extract
• Ginger Extract
• Turmeric Extract
• Ginseng Extract
• 6.6. Global Cold And Flu Supplements Market, Sub-Segmentation Of Natural Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flavonoids
• Polyphenols
• Essential Oils
• Probiotics
• Amino Acids

7. Cold And Flu Supplements Market Regional And Country Analysis

• 7.1. Global Cold And Flu Supplements Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cold And Flu Supplements Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cold And Flu Supplements Market

• 8.1. Asia-Pacific Cold And Flu Supplements Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cold And Flu Supplements Market

• 9.1. China Cold And Flu Supplements Market Overview
• 9.2. China Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cold And Flu Supplements Market

• 10.1. India Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cold And Flu Supplements Market

• 11.1. Japan Cold And Flu Supplements Market Overview
• 11.2. Japan Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cold And Flu Supplements Market

• 12.1. Australia Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cold And Flu Supplements Market

• 13.1. Indonesia Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cold And Flu Supplements Market

• 14.1. South Korea Cold And Flu Supplements Market Overview
• 14.2. South Korea Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cold And Flu Supplements Market

• 15.1. Western Europe Cold And Flu Supplements Market Overview
• 15.2. Western Europe Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cold And Flu Supplements Market

• 16.1. UK Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cold And Flu Supplements Market

• 17.1. Germany Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cold And Flu Supplements Market

• 18.1. France Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cold And Flu Supplements Market

• 19.1. Italy Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cold And Flu Supplements Market

• 20.1. Spain Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cold And Flu Supplements Market

• 21.1. Eastern Europe Cold And Flu Supplements Market Overview
• 21.2. Eastern Europe Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cold And Flu Supplements Market

• 22.1. Russia Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cold And Flu Supplements Market

• 23.1. North America Cold And Flu Supplements Market Overview
• 23.2. North America Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cold And Flu Supplements Market

• 24.1. USA Cold And Flu Supplements Market Overview
• 24.2. USA Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cold And Flu Supplements Market

• 25.1. Canada Cold And Flu Supplements Market Overview
• 25.2. Canada Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cold And Flu Supplements Market

• 26.1. South America Cold And Flu Supplements Market Overview
• 26.2. South America Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cold And Flu Supplements Market

• 27.1. Brazil Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cold And Flu Supplements Market

• 28.1. Middle East Cold And Flu Supplements Market Overview
• 28.2. Middle East Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cold And Flu Supplements Market

• 29.1. Africa Cold And Flu Supplements Market Overview
• 29.2. Africa Cold And Flu Supplements Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cold And Flu Supplements Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cold And Flu Supplements Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cold And Flu Supplements Market Competitive Landscape And Company Profiles

• 30.1. Cold And Flu Supplements Market Competitive Landscape
• 30.2. Cold And Flu Supplements Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Cold And Flu Supplements Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group plc
• 31.2. Haleon plc
• 31.3. Perrigo Company plc
• 31.4. Amway Corporation
• 31.5. Nu Skin Enterprises Inc.
• 31.6. The Vitamin Shoppe Inc.
• 31.7. NOW Health Group Inc.
• 31.8. Nature's Sunshine Products Inc.
• 31.9. Nature's Way Products LLC
• 31.10. Nordic Naturals Inc.
• 31.11. Orthomol GmbH
• 31.12. Weefsel Pharma Pvt. Ltd.
• 31.13. AdvaCare Pharma USA
• 31.14. Zarbee's Naturals LLC
• 31.15. Neurobiologix Inc.

32. Global Cold And Flu Supplements Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold And Flu Supplements Market

34. Recent Developments In The Cold And Flu Supplements Market

35. Cold And Flu Supplements Market High Potential Countries, Segments and Strategies

• 35.1 Cold And Flu Supplements Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cold And Flu Supplements Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cold And Flu Supplements Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34797_Cold_And_Flu_Supplements_GMR_2025